Gormally, E, Vineis, P, Matullo, G, Veglia, F, Caboux, E, Le Roux, E, Peluso, M, Garte, S, Guarrera, S, Munnia, A, Airoldi, L, Autrup, H, Malaveille, C, Dunning, A, Overvad, K, Tjonneland, A, Lund, E, Clavel-Chapelon, F, Boeing, HH, Trichopoulou, A, Palli, D, Krogh, V, Tumino, R, Panico, S, Bueno de Mesquita, HB, Peeters, PHM, Pera, G, Martinez, C, Dorronsoro, M, Barricarte, A, Navarro, C, Quiros, JR, Hallmans, G, Day, NE, Key, TJ, Saracci, R, Kaaks, R, Riboli, E & Hainaut, P 2006, '
TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence: a prospective study.',
Cancer Research, vol. 66, no. 13, pp. 6871-6876.